The FDA has fast-tracked Invectys’ CAR-T therapy in renal cell carcinoma. Credit: Nemes Laszlo via Shutterstock. The US Food and Drug Administration (FDA) has granted
As Verily aims to get on track, the Alphabet life science company has hired Andrew Trister, an oncologist and veteran of big technology companies and
Tel Aviv, Israel / Vancouver, Canada, Aug. 01, 2023 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (NASDAQ: CMND) (CSE: CMND), (FSE: CWY) (“Clearmind” or “the company”),
Hu14.18 is in development for the treatment of newly diagnosed high-risk neuroblastoma. Credit: Kateryna Kon/Shutterstock.com. Renaissance Pharma has signed an agreement to in-license St Jude
The contract is divided into two option periods, one advanced development option worth $121m, and the second procurement option valued at $583m over a five-year
Both Pfizer and Arvinas equally share development costs, commercialisation expenses, and profits of vepdegestrant. Image Credit: ST.art / Shutterstock. Arvinas and Pfizer have been awarded
You’re reading the web edition of STAT Health Tech, our guide to how tech is transforming the life sciences. Sign up to get this newsletter delivered in